Literature DB >> 32524946

Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.

Andreas Walker1,2, Torsten Houwaart2,3, Tobias Wienemann3, Malte Kohns Vasconcelos3, Daniel Strelow3, Tina Senff1, Lisanna Hülse3, Ortwin Adams1, Marcel Andree1, Sandra Hauka1, Torsten Feldt4, Björn-Erik Jensen4, Verena Keitel4, Detlef Kindgen-Milles5, Jörg Timm1, Klaus Pfeffer3, Alexander T Dilthey3.   

Abstract

We whole-genome sequenced 55 SARS-CoV-2 isolates from Germany to investigate SARS-CoV-2 outbreaks in 2020 in the Heinsberg district and Düsseldorf. While the genetic structure of the Heinsberg outbreak indicates a clonal origin, reflecting superspreading dynamics from mid-February during the carnival season, distinct viral strains were circulating in Düsseldorf in March, reflecting the city's international links. Limited detection of Heinsberg strains in the Düsseldorf area despite geographical proximity may reflect efficient containment and contact-tracing efforts.

Entities:  

Keywords:  COVID-19; Düsseldorf; Heinsberg; SARS-CoV-2; artic; genomic epidemiology; nanopore; superspreading

Mesh:

Substances:

Year:  2020        PMID: 32524946      PMCID: PMC7336109          DOI: 10.2807/1560-7917.ES.2020.25.22.2000746

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


We report on the genetic structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in North-Rhine Westphalia, Germany’s most populous state (18 million inhabitants). Our analysis includes the ‘Heinsberg outbreak’ [1], which started in the second half of February 2020 – comprising a superspreading event at a carnival session in Gangelt, a small municipality of ca 12,000 inhabitants on the border between Germany and the Netherlands – and subsequent outbreak dynamics in March, in the state capital Düsseldorf, located 70 km from Gangelt and an international economic and air travel hub of ca 600,000 inhabitants.

Severe acute respiratory syndrome coronavirus 2 genome sequencing

The institute of virology at Düsseldorf University Hospital was one of the first laboratories to offer SARS-CoV-2 diagnostics in North-Rhine Westphalia. A total of 55 SARS-CoV-2 isolate samples were acquired from diagnostic swabs sent to this institute in February and March 2020. Of these, 10 were directly linked to the Heinsberg outbreak (obtained from medical practices in the Heinsberg district or from patients treated at Düsseldorf University Hospital who were Heinsberg district residents) and 45 originated from the city of Düsseldorf and surrounding districts. RNA extraction and reverse transcription were carried out as previously described [2]. DNA amplification and sequencing on the Oxford Nanopore platform were carried out according to the Artic protocol [3,4] (Supplementary Text), yielding between 31 and 582 Mb of raw sequencing data per sample (Supplementary Table S1). Bioinformatic analysis was based on the Artic pipelines and additional manual curation was carried out (Supplementary Text), yielding completely resolved genomes with 2–13 polymorphic positions (Supplementary Table S2) relative to the SARS-CoV-2 reference genome [5]. Of note, we observed evidence for ambiguities at polymorphic positions in 11 of 55 samples (Supplementary Table S2); for one such sample (NRW-39; 13 positions called as multi-allelic), PCR was repeated and a separate sequencing run was carried out, confirming the detected ambiguities (Supplementary Text). Further work is necessary to investigate whether ambiguities represent within-patient viral quasispecies. In a proof-of-concept experiment, we also successfully sequenced reverse-transcribed viral cDNA from patient material without an intermediate PCR-based amplification step (Supplementary Text), potentially enabling simplified sample preparation and increased read lengths for some samples in the future.

Ethical statement

Our study was Institutional Review Board (IRB)-approved by the ethics committee of the Heinrich Heine University Düsseldorf (#2020–839).

The Heinsberg outbreak

The first cases of SARS-CoV-2 infection in Germany were detected in late January 2020 and could be linked to recent travel to Northern Italy and China [1]. On 24 and 25 February 2020, however, two members of the same household from the Heinsberg district with no known travel history to SARS-CoV-2 risk areas were diagnosed with SARS-CoV-2; by 28 February 2020, the number of confirmed infections in the Heinsberg district had grown to 37; by 22 April 2020, to > 1,700 [6]. Contact tracing later showed that many of the early SARS-CoV-2 cases could be linked to a carnival session attended by the two index cases. The carnival event was held on 15 February 2020 in the municipality of Gangelt, which is part of the Heinsberg district [1]. Epidemiological investigation revealed that the index cases had travelled to the Netherlands, not considered a risk area at the time, 7 days prior to attending the Gangelt carnival session. The ‘Heinsberg outbreak’ represented one of the first large-scale SARS-CoV-2 outbreaks in Germany, seeded by community transmission and amplified by superspreading-type dynamics. Genomic analysis of 10 SARS-CoV-2 isolates from the Heinsberg outbreak, sampled between 25 and 28 February and including those from the index cases, demonstrated the clonal origin of the outbreak (Figure); all Heinsberg samples shared the same two mutations compared to the SARS-CoV-2 reference genome (Supplementary Table S2). Viral diversity in the Heinsberg samples varied between two and six polymorphic positions relative to the SARS-CoV-2 reference genome, and five distinct viral variants (i.e. haplotypes) could be identified (Supplementary Table S2).
Figure

Minimum spanning tree of severe acute respiratory syndrome coronavirus 2 sequences, showing 44 unambiguouslya resolved genomes from the Heinsberg district (n = 8) and the Düsseldorf area (n = 36), Germany, February–March 2020

Minimum spanning tree of severe acute respiratory syndrome coronavirus 2 sequences, showing 44 unambiguouslya resolved genomes from the Heinsberg district (n = 8) and the Düsseldorf area (n = 36), Germany, February–March 2020 GISAID: Global Initiative on Sharing All Influenza Data; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; US: United States. a Eleven isolate genomes from 55 in our study with ambiguities are not considered ‘unambiguously resolved’ for the purposes of this analysis and are thus omitted. The original Wuhan SARS-CoV-2 reference genome; and a sample of closely related publicly available SARS-CoV-2 genomes from GISAID (distance to any of the Heinsberg/Düsseldorf genomes of 0 or 1; see Supplementary Text for details) are included in the analysis. Dashed and solid edges without adjacent numbers indicate distances of 0 and 1, respectively; all other distances are shown explicitly. An analysis (Supplementary Text) of other publicly available SARS-CoV-2 sequences did not reveal an obvious origin of the Heinsberg outbreak (Supplementary Table S3); the Heinsberg isolates are not related to early sequences from other German outbreak areas (Bavaria, Baden-Wuerttemberg), and, despite intense Dutch viral sampling (585 available viral genomes from the Netherlands at the time of analysis), our analysis identified only two closely related isolates from the Netherlands (one collected on 21 March, the other with undefined collection date). The role of the index cases’ short vacation in the Netherlands 7 days before the Gangelt carnival session [7], while suggestive in terms of reported SARS-CoV-2 incubation periods thus remains ambiguous [8]. Moreover, large numbers of closely related isolates are circulating in many countries, for example England, Wales, and Iceland (Supplementary Table S3). The small number of polymorphisms shared by all samples in the Heinsberg outbreak (n = 2), compared with a maximum number of six per-isolate polymorphic positions in the same samples, likely acquired over a period of a few weeks, is compatible with a relatively recent introduction from China.

Düsseldorf outbreak dynamics

The first SARS-CoV-2 cases in Düsseldorf, 70 km from Gangelt, were diagnosed in early March 2020 [9]; as at 21 April 2020, the outbreak had grown to more than 900 confirmed cases [10]. The set of 55 whole-genome-sequenced isolates included 45 samples from Düsseldorf and nearby districts, collected between 3 and 23 March. A minimum spanning tree analysis of 44 unambiguously resolved viral sequences (Figure) showed that there were at least five clusters of viral stains circulating in the Düsseldorf area; the number of polymorphic positions relative to the SARS-CoV-2 reference genome in the Düsseldorf samples varied between 2 and 13 (Supplementary Table S2). Closely related strains (distance 0 or 1) were found in Australia, the United Kingdom, the United States and many other countries (Supplementary Table S3), strongly suggesting multiple independent introduction events. Of note, four ‘Düsseldorf area’ isolates clustered with the Heinsberg outbreak (Figure 1); of these, two were collected from residents of a district next to Heinsberg, who had been treated at the Düsseldorf University Hospital, and two remained of unclear origin (patient data not available). Thus, there was no evidence for widespread community circulation of Heinsberg-derived SARS-CoV-2 strains in the Düsseldorf area.

Illumina validation

To verify the accuracy of Nanopore-based viral assembly, additional Illumina sequencing was carried out for the first 11 samples, according to date of collection, of our cohort (Supplementary Table S1; Supplementary Text); data analysis was carried out with iVar [11]. For 41 of 45 polymorphic positions identified by either Nanopore or Illumina across the 11 samples, the called alleles agreed; manual inspection of the discordant positions revealed low coverage for two discordant positions and one missed multi-allelic call for each sequencing technology (Supplementary Table S4).

Discussion

Since its emergence in the Chinese city of Wuhan in late 2019, SARS-CoV-2 has infected more than 6 million individuals and led to more than 370,000 deaths worldwide as at 03 June 2020 [12]. As SARS-CoV-2 case numbers and the social and economic consequences of social distancing and lock-down measures continue to rise, many countries are facing difficult trade-offs. Improved methods to characterise the dynamics of viral transmission are urgently needed. More than 10,000 globally sourced SARS-CoV-2 genomes are publicly available, and powerful data sharing and analysis platforms like the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database [13] and Nextstrain [14] enable the collaborative analysis of viral population structure on a global level. Additional insights into transmission dynamics can be gained from focused investigations of individual outbreaks and by integrating genomic data with classical epidemiology. Here we have investigated the genetic structure of two SARS-CoV-2 outbreaks, which occurred at two nearby locations in North-Rhine Westphalia using Nanopore sequencing, which has additional applications in many fields such as human genetics [15] and microbial metagenomics [16]. We have demonstrated the clonal origin of the Heinsberg outbreak. This is consistent with available epidemiological data pointing to a carnival session in Gangelt as the epicentre of the outbreak [1]. The lack of association between the Heinsberg samples and other early German outbreak isolates is suggestive of a separate introduction event, possibly via the Netherlands, China, or a third country. By contrast, SARS-CoV-2 isolates circulating in Düsseldorf were highly polyclonal and could be grouped into at least five clusters of viral haplotypes. Despite the geographical proximity between Heinsberg and Düsseldorf, only four of 36 unambiguously resolved samples from the Düsseldorf area clustered with the Heinsberg outbreak, and two of these were derived from residents of a district neighbouring Heinsberg. Limited detection of Heinsberg strains in the Düsseldorf area may reflect the effectiveness of the contact-tracing efforts conducted by the German public health authorities; of note, ‘lockdown’-type restrictions with limits on public gatherings in Germany were only imposed on 23 March 2020 [17], i.e. on the day on which the last sample of our study was collected. More extensive sampling of SARS-CoV-2 isolates from North-Rhine Westphalia will be required to investigate the effect of various containment measures on transmission chains at a genomic level. Consistent with reports from Iceland [18], New York [19], and data on Nextstrain, our study has demonstrated the simultaneous circulation of distinct viral variants (i.e. haplotypes) in a metropolitan region. In the Heinsberg outbreak, we could identify five distinct variants. As SARS-CoV-2 genomes continue to diverge as part of ongoing viral evolution, the application of genomic epidemiology [20,21] for the identification and targeted interruption of viral transmission chains will become increasingly feasible.
  13 in total

1.  Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples.

Authors:  Joshua Quick; Nathan D Grubaugh; Steven T Pullan; Ingra M Claro; Andrew D Smith; Karthik Gangavarapu; Glenn Oliveira; Refugio Robles-Sikisaka; Thomas F Rogers; Nathan A Beutler; Dennis R Burton; Lia Laura Lewis-Ximenez; Jaqueline Goes de Jesus; Marta Giovanetti; Sarah C Hill; Allison Black; Trevor Bedford; Miles W Carroll; Marcio Nunes; Luiz Carlos Alcantara; Ester C Sabino; Sally A Baylis; Nuno R Faria; Matthew Loose; Jared T Simpson; Oliver G Pybus; Kristian G Andersen; Nicholas J Loman
Journal:  Nat Protoc       Date:  2017-05-24       Impact factor: 13.491

2.  Nanopore sequencing and assembly of a human genome with ultra-long reads.

Authors:  Miten Jain; Sergey Koren; Karen H Miga; Josh Quick; Arthur C Rand; Thomas A Sasani; John R Tyson; Andrew D Beggs; Alexander T Dilthey; Ian T Fiddes; Sunir Malla; Hannah Marriott; Tom Nieto; Justin O'Grady; Hugh E Olsen; Brent S Pedersen; Arang Rhie; Hollian Richardson; Aaron R Quinlan; Terrance P Snutch; Louise Tee; Benedict Paten; Adam M Phillippy; Jared T Simpson; Nicholas J Loman; Matthew Loose
Journal:  Nat Biotechnol       Date:  2018-01-29       Impact factor: 54.908

3.  Nextstrain: real-time tracking of pathogen evolution.

Authors:  James Hadfield; Colin Megill; Sidney M Bell; John Huddleston; Barney Potter; Charlton Callender; Pavel Sagulenko; Trevor Bedford; Richard A Neher
Journal:  Bioinformatics       Date:  2018-12-01       Impact factor: 6.931

Review 4.  Tracking virus outbreaks in the twenty-first century.

Authors:  Nathan D Grubaugh; Jason T Ladner; Philippe Lemey; Oliver G Pybus; Andrew Rambaut; Edward C Holmes; Kristian G Andersen
Journal:  Nat Microbiol       Date:  2018-12-13       Impact factor: 17.745

5.  An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar.

Authors:  Nathan D Grubaugh; Karthik Gangavarapu; Joshua Quick; Nathaniel L Matteson; Jaqueline Goes De Jesus; Bradley J Main; Amanda L Tan; Lauren M Paul; Doug E Brackney; Saran Grewal; Nikos Gurfield; Koen K A Van Rompay; Sharon Isern; Scott F Michael; Lark L Coffey; Nicholas J Loman; Kristian G Andersen
Journal:  Genome Biol       Date:  2019-01-08       Impact factor: 13.583

6.  Strain-level metagenomic assignment and compositional estimation for long reads with MetaMaps.

Authors:  Alexander T Dilthey; Chirag Jain; Sergey Koren; Adam M Phillippy
Journal:  Nat Commun       Date:  2019-07-11       Impact factor: 14.919

7.  Introductions and early spread of SARS-CoV-2 in the New York City area.

Authors:  Ana S Gonzalez-Reiche; Matthew M Hernandez; Emilia Mia Sordillo; Viviana Simon; Harm van Bakel; Mitchell J Sullivan; Brianne Ciferri; Hala Alshammary; Ajay Obla; Shelcie Fabre; Giulio Kleiner; Jose Polanco; Zenab Khan; Bremy Alburquerque; Adriana van de Guchte; Jayeeta Dutta; Nancy Francoeur; Betsaida Salom Melo; Irina Oussenko; Gintaras Deikus; Juan Soto; Shwetha Hara Sridhar; Ying-Chih Wang; Kathryn Twyman; Andrew Kasarskis; Deena R Altman; Melissa Smith; Robert Sebra; Judith Aberg; Florian Krammer; Adolfo García-Sastre; Marta Luksza; Gopi Patel; Alberto Paniz-Mondolfi; Melissa Gitman
Journal:  Science       Date:  2020-05-29       Impact factor: 47.728

Review 8.  Towards a genomics-informed, real-time, global pathogen surveillance system.

Authors:  Jennifer L Gardy; Nicholas J Loman
Journal:  Nat Rev Genet       Date:  2017-11-13       Impact factor: 53.242

9.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application.

Authors:  Stephen A Lauer; Kyra H Grantz; Qifang Bi; Forrest K Jones; Qulu Zheng; Hannah R Meredith; Andrew S Azman; Nicholas G Reich; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-03-10       Impact factor: 25.391

10.  Spread of SARS-CoV-2 in the Icelandic Population.

Authors:  Daniel F Gudbjartsson; Agnar Helgason; Hakon Jonsson; Olafur T Magnusson; Pall Melsted; Gudmundur L Norddahl; Jona Saemundsdottir; Asgeir Sigurdsson; Patrick Sulem; Arna B Agustsdottir; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Gudmundur Georgsson; Olafia S Gretarsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Hilma Holm; Brynjar O Jensson; Aslaug Jonasdottir; Frosti Jonsson; Kamilla S Josefsdottir; Thordur Kristjansson; Droplaug N Magnusdottir; Louise le Roux; Gudrun Sigmundsdottir; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Arthur Löve; Gisli Masson; Ingileif Jonsdottir; Alma D Möller; Thorolfur Gudnason; Karl G Kristinsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  N Engl J Med       Date:  2020-04-14       Impact factor: 91.245

View more
  17 in total

1.  Decision analysis support for evaluating transmission risk of COVID-19 in places where people gather.

Authors:  Valerie Hongoh; David Maybury; Jérôme Levesque; Aamir Fazil; Ainsley Otten; Patricia Turgeon; Lisa Waddell; Nicholas H Ogden
Journal:  Can Commun Dis Rep       Date:  2021-11-10

2.  Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts.

Authors:  Ortwin Adams; Marcel Andrée; Derik Hermsen; Nadine Lübke; Jörg Timm; Heiner Schaal; Lisa Müller
Journal:  J Virol Methods       Date:  2022-06-17       Impact factor: 2.623

3.  Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches.

Authors:  Teufik Goletic; Rijad Konjhodzic; Nihad Fejzic; Sejla Goletic; Toni Eterovic; Adis Softic; Aida Kustura; Lana Salihefendic; Maja Ostojic; Maja Travar; Visnja Mrdjen; Nijaz Tihic; Sead Jazic; Sanjin Musa; Damir Marjanovic; Mirsada Hukic
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

4.  Settings of virus exposure and their implications in the propagation of transmission networks in a COVID-19 outbreak.

Authors:  Ngai Sze Wong; Shui Shan Lee; Tsz Ho Kwan; Eng-Kiong Yeoh
Journal:  Lancet Reg Health West Pac       Date:  2020-11-09

5.  Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore.

Authors:  John R Tyson; Phillip James; David Stoddart; Natalie Sparks; Arthur Wickenhagen; Grant Hall; Ji Hyun Choi; Hope Lapointe; Kimia Kamelian; Andrew D Smith; Natalie Prystajecky; Ian Goodfellow; Sam J Wilson; Richard Harrigan; Terrance P Snutch; Nicholas J Loman; Joshua Quick
Journal:  bioRxiv       Date:  2020-09-04

6.  Haploflow: Strain-resolved de novo assembly of viral genomes.

Authors:  A Fritz; A Bremges; Z-L Deng; T-R Lesker; J Götting; T Ganzenmüller; A Sczyrba; A Dilthey; F Klawonn; A C McHardy
Journal:  bioRxiv       Date:  2021-01-26

7.  Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.

Authors:  Rowena A Bull; Thiruni N Adikari; James M Ferguson; Jillian M Hammond; Igor Stevanovski; Alicia G Beukers; Zin Naing; Malinna Yeang; Andrey Verich; Hasindu Gamaarachchi; Ki Wook Kim; Fabio Luciani; Sacha Stelzer-Braid; John-Sebastian Eden; William D Rawlinson; Sebastiaan J van Hal; Ira W Deveson
Journal:  Nat Commun       Date:  2020-12-09       Impact factor: 14.919

8.  Link between COVID-19-related in-hospital mortality in continental France administrative areas and weather: an ecological study.

Authors:  Mehdi Mejdoubi; Mehdi Djennaoui; Xavier Kyndt
Journal:  BMJ Open       Date:  2021-03-11       Impact factor: 2.692

9.  Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.

Authors:  Susanne Homolka; Laura Paulowski; Sönke Andres; Doris Hillemann; Ruwen Jou; Gunar Günther; Mareli Claassens; Martin Kuhns; Stefan Niemann; Florian P Maurer
Journal:  Emerg Infect Dis       Date:  2020-09-21       Impact factor: 6.883

10.  Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.

Authors:  Bjoern Jensen; Nadine Luebke; Torsten Feldt; Verena Keitel; Timo Brandenburger; Detlef Kindgen-Milles; Matthias Lutterbeck; Noemi F Freise; David Schoeler; Rainer Haas; Alexander Dilthey; Ortwin Adams; Andreas Walker; Joerg Timm; Tom Luedde
Journal:  Lancet Reg Health Eur       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.